level or profiling of performance at the hospital level. 10 Furthermore, it has been found that readmissions are rather heterogeneous in nature and that many readmissions are unrelated to the index stay and thus not easily predicted with common clinical variables. 11 Implementing interventions to reduce readmission after AMI will require an understanding of the patient characteristics associated with readmission, as knowledge of relevant patient characteristics within one community will help physicians stratify AMI patients according to risk of readmission and assist with developing discharge plans. 12 With the present study, we aimed to determine the risk factors for readmission of the AMI survivors diagnosed in the four facilities of Methodist Health System (MHS) in the Dallas metropolitan area in order to facilitate interventions to reduce the readmission rate. MHS comprises of four community-based hospitals (including one inner-city teaching hospital and referral center) in north Texas, USA. Secondary objectives were to identify the reason for readmission, the risk factors for early readmission (within 1 week) as well as for cardiacrelated readmission (those related to re-infarction, congestive heart failure [CHF] or medication side effects).
Methodology Study design
Using a retrospective cohort design, we identified all the admissions for AMI (Non-ST segment elevation AMI -NSTEMI, and ST segment elevation AMI -STEMI) 13 within the four facilities of MHS from October 2011 to September 2014. We used the Crimson Database (performance improvement software) to identify the cases, and then performed a manual review of the electronic medical records. We compared patients who were and were not re-hospitalized to determine the risk factors for readmission. We included 100% of the readmitted patients, and for the non-readmitted patients, we randomly selected a third of the patients. This was based on a sample calculation using the computer program G-power 3.1 14 to detect a small effect (Cohen's d = 0.2) with 80% power and allocation ratio 1:2 for readmitted vs. non- 
Inclusion and Exclusion Criteria
Inclusion criteria were patients of any age, sex and race with diagnosis of NSTEMI or STEMI; we also identified those with 30-day readmissions for any diagnosis. For patients with more than one readmission after the index admission, only the first one was considered for analysis. Reasons for exclusion were in-hospital death, transfer to another facility and discharge against medical advice. Patients with planned readmissions for elective procedures were also excluded, with the exception of planned coronary artery bypass grafting (CABG), as this is specifically stated as a penalty for AMI readmissions in the Hospital Readmission Reduction Program. 15 Figure 1 describes the study population.
Outcome measures
Demographic data, clinical parameters, comorbidities, medications at discharge, information about the index hospitalization and readmission were collected from the electronic medical records. The principal reason for readmission was extracted from the discharge summary of the readmission. The readmission rate was calculated as patients who were readmitted 30 days after discharge for AMI divided by the total of people with AMI in the MHS.
CHF and ejection fraction (EF) were classified according to the 2013 American Heart Association Guidelines for CHF. The glomerular filtration rate (GFR) was calculated with the Modification of Diet in Renal Disease equation 17 . Optimal medical therapy was considered if the patient was discharged on dual antiplatelet therapy, statin, angiotensin-converting enzyme inhibitor / angiotensin receptor blocker (ACEI/ARB) and beta blocker.
Early readmission was defined as admission within 7 days of discharge. Cardiac related readmission was defined as any coronary artery event (NSTEMI, STEMI, stent thrombosis, angina), CHF, arrhythmias or side effect due to medications related to coronary disease.
Statistical Analysis
Descriptive analyses were performed for all continuous variables. Mean ± standard deviation (SD) is presented for normally distributed variables and median ± SD is presented for non-normal variables. Normally distributed continuous variables were analyzed with Student's t-test and nonnormally distributed continuous variables were analyzed with nonparametric Wilcoxon-Mann-Whitney test. Categorical variables were analyzed using chi-square test or Fisher's exact test for smaller samples.
Patient demographics, comorbidities, medication, insurance, in-hospital outcomes, and discharge location were evaluated for inclusion in the prediction model using chi-square and Student t-test comparisons and univariate logistic regression. Except for age and days to catheterization, all independent variables considered in the analysis were specified in categorical form. Each level of a categorical variable was considered to be a unique risk factor. Both forward and backward step logistic 1= quetiapine overdose (0.3%), psychosis (0.6%) 2= cholecystitis (1.3%), acute urinary retention (0.3%) 3= acute retroperitoneal bleeding (0.3%), access site hematoma (0.3%), epistaxis (0.3%), subdural hematoma (0.6%), subarachnoid hemorrhage (0.3%). 4= hypoglycemia (0.6%), hyponatremia (0.9%), volume depletion (0.6%), symptomatic anemia (0.6%), metastatic cancer complications (0.6%). 5= Headache (0.3%), syncope (1.3%), seizures (0.6%), stroke (3.6%) 6 = AKI (1.9%), ESRD volume overload (3.6%), chest pain or hypotension during dialysis (1.9%). 7 = UTI (1.4%), sepsis (2.6%), cellulitis (3.6%), meningoencephalitis (0.3%), neutropenia (0.3%). 8 = GI bleeding (3.8%), diarrhea (5.1%), biliary colic (1.5%), eosinophilic esophagitis (0.6%), constipation (0.6%). 9 = COPD exacerbation (4.4%), pneumonia (4.9%), PE/DVT (3.4%), pulmonary fibrosis (0.7%), pleural effusion (2.4%). 10 = CHF exacerbation (14.5%), NSTEMI (9.35%), STEMI (2.3%), angina (3.5%), unstable angina (3.2%), arrhythmias (4.8%), Prinzmetal angina (0.3%), pericarditis (0.3%), hypertensive urgency (1.2%), medication side effects (1.2%), atypical chest pain (2.2%). Sampling tree describing the patients in our study.
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International Cardiovascular Forum Journal 4 (2015) DOI: 10.17987/icfj.v4i0.155 regression were conducted using only factors with univariate associations with the composite end point of readmission within 30 days, to determine factors to be included in the multivariable model using an γ of 0.10. The same process was repeated twice for the endpoints of early readmission (within 7 days) and cardiac-related readmission within 30 days. Factors remaining in the multivariate models were evaluated and only factors with an γ of <0.10 were included in the final prediction model. First-order interaction terms were evaluated for the variables in final model. The methods by Lemeshow and Hosmer were used for assessing the model calibration. 18 The area under the receiver operating characteristic (ROC) curve C-statistic (ROC area) was estimated to assess the discriminating ability of the final multivariate logistic regression model. 19 Analyses were performed using STATA version 13.0 (StataCorp LP, College Station, TX).
Results
We identified 2958 cases of AMI and 334 were readmitted (11.3%). As described in Figure 1 , the final sample for analysis included 310 readmitted and 652 non-readmitted patients. The principal causes of readmission were cardiac related (42%), followed by respiratory (15%) and gastrointestinal (11%) as presented in Figure 2 . Separate analyses for the early 7-and 15-day readmissions showed the same pattern with only slight changes in renal and infectious causes (fourth and fifth most common causes of readmission). Table 1 describes the patient demographics, comorbidities, admission characteristics and discharge medications. The difference between readmitted and non-readmitted patients is evaluated with the statistical test described in the footnote. Readmitted patients were more likely to be older, female, have Medicare as insurance, longer length of stay and to have been discharged to a skilled nursing facility (SNF). Furthermore, we found that readmitted patients were more likely to have had an NSTEMI, lower EF, cardiac catheterization performed later than non-readmitted patients and suboptimal medical therapy at discharge. Specifically, patients were less likely to have had aspirin, ACEI/ARB, and a second antiplatelet (clopidogrel, prasugrel or ticagrelor). Comorbidities significantly associated with readmission were diabetes mellitus (DM), hypertension (HTN), chronic kidney disease (CKD), pneumonia (PNA), chronic obstructive pulmonary disease (COPD), stroke, dementia, tobacco, alcohol or drug abuse and major psychiatric disorder.
As described in Figure 3 , 42% of the readmissions (131) happened during the first week, and 68% occur in the first 2 weeks after discharge. The median time for readmission was 10 days (mean 11.7, SD 8.5 days). The columns represent absolute number of readmissions per day after index discharge.
Risk factors associated with 30-day emergent readmission, which were included in the multivariate model are described in Table 2 . Gender, length of stay, type of infarction, discharge destination facility, comorbidities such as COPD, PNA, dementia, drug/alcohol abuse were not significantly associated with the readmission risk. Factors such as age, days to catheterization, complete medical therapy, comorbidities such as DM, HTN, stroke and major psychiatric disorders; insurance; We performed secondary analysis with the readmitted patients to identify risk factors associated with cardiac related readmission and early readmissions, within the first week after discharge. These analyses were performed only with the subset of readmitted patients. As described in Table 3 , being discharged to a nursing home or SNF and having Medicare as insurance was significantly associated with decreased odds of being readmitted for a cardiac-related reason. On the other hand, being readmitted during the first week, having a major psychiatric disorder and patients with systolic CHF had significantly higher odds of being readmitted for a cardiac-related reason. The ROC of this analysis was 0.74, 95% CI: 0.69-0.80. The Hosmer-Lemeshow γ2 was 9.35 with a p-value of 0.31 > 0.05 indicating a significant goodness-of-fit. Table 4 describes the analysis of the early readmission. Consistent with the cardiac-related readmission, been discharged to a nursing home or SNF was significantly associated with decreased odds of having an early readmission and have a cardiac-related readmission significantly increased the odds of early readmission. The ROC of this analysis was 0.66, 95% CI: 0.59-0.74. The Hosmer-Lemeshow γ2 was 9.07 with a p-value of 0.34 > 0.05 indicating a significant goodnessof-fit. No interaction terms were found in both cardiac and early readmission analysis.
Discussion Findings
We have reviewed the risk factors and developed a comprehensive model for estimating risk of 30-day readmission after AMI based on the MHS in Dallas Metropolitan Area.
Systematic reviews have shown that identification of consistent and reliable predictors of readmission requires appropriately local analysis to implement risk-based interventions to reduce readmission after AMI. Although variable selection may in part be informed by the literature, empirical development and validation analyses using appropriate local data sets and rigorous hierarchical statistical methods are needed, because patient-level predictors of readmission (social and behavioral variables, comorbidities) are likely to account for variation even after developing validated risk-standardized statistical models. 10 These variables are frequently not documented in the electronic medical records. 20 With the present study, we aimed to determine the local factors for readmission in order to implement directed interventions to reduce them.
The reasons for readmission found in our study were consistent with previous studies. 7, 21 In our sample, 43% of the readmissions were cardiac related, 14% due to acute CHF, 11% due to reinfarction (most of them NSTEMI) and almost 5% arrhythmia-related. Pulmonary, gastrointestinal, infectious and renal causes account for another significant amount of the readmissions, emphasizing that comprehensive strategies of care in patients with AMI need to be deployed to incorporate timely treatment of both cardiovascular and non-cardiovascular diseases to prevent future hospitalizations.
Data Interpretation
Absolute readmission rates reported in this study were lower than in some prior publications. 6, 11, 21, 22, 23, 24 However, it is difficult to directly compare rates, due to several factors: previous analysis have focused only on Medicare patients 7, 10 , only patients with STEMI 21 , or only patients undergoing PCI (percutaneous coronary intervention) 23, 24 .
A recent study looking at elderly NSTEMI survivors found, contrary to our results, that rehospitalization rates did not rise substantially with advancing age, but the mortality rate was twice as much. Similarly to our data, they demonstrated that the readmission is often for non-cardiac diagnoses. 25 Contrary to previously publications 26, 27 , patients discharged to SNF had decreased odds of being readmitted in the multivariate analysis for early and cardiac related readmission. On the other hand, univariate analysis of all 30-day readmissions, showed that patients discharged to rehabilitation and SNF were more likely to be readmitted. These contradictory results could be explained by the different functional levels, multiple comorbidities of patients deemed to have a skilled need instead of going home and the different SNF transfer rates that vary considerably across hospitals.
Our model fits reasonably well. Compared to previously developed 30-day readmission models, our model has better discrimination with ROC curves as those range between 0.63 and 0.67. 21, 23, 24, 28 
Limitations
This study is not free of limitations. We are not including death as an outcome, as we did not have the capacity to follow patients outside of our system. Because of the PCI capacity of our four institutions, our report may not be generalizable to medical centers performing predominantly primary thrombolytic therapy. Third, the retrospective nature of our study conceptually limits the inferential capacity of our model.
We detected readmissions using MHS data, which includes four facilities but we did not have the power to detect admissions to other health systems. To completely ascertain the end point of readmission, it has been suggested to use Medicare data 10 . Nonetheless, this approach would only analyze patients over the age of 65 years and not include health maintenance organization (HMO)-covered beneficiaries under Medicare, which in our sample were 9%, but in some geographic regions can represent more than 50% 21 . On the other hand, hospitallevel adjusted readmission rates developed using Medicare claims have been demonstrated to be highly correlated to the use of hospital medical records, (correlation, 0.98). 27 We have excluded patients with planned readmissions which might account for some selection bias in our final sample. Most of these patients had gastrointestinal or orthopedic procedures performed. Nonetheless, patients with triple vessel disease and residual high grade coronary stenosis that were readmitted for CABG were included in our sample, decreasing the likelihood of excluding more symptomatic cardiac patients in our analysis.
Studies looking for both 30-day and 1-year readmissions after AMI have found significant variation in predictors depending on the cause and timing of readmission, suggesting that all-cause 30-day readmission rates may be too simplistic, and perhaps even misleading, as a hospital performance metric.
11, 24

Clinical implication
We expanded on the science by adding risk factors derived from the time to cardiac catheterization since admission and destination at discharge, both of which were associated with readmission. We contributed to the existing literature a clinical risk model for AMI 30-day readmission in the community setting, taking into account all ages, insurance status and treatment modality for the index AMI.
Conclusion
We present a prediction model for 30-day readmission following AMI. We present novel and addressable patient risk factors derived from the index hospitalization and their utility in predicting readmission. Our model can be used to develop routine surveillance systems when planning discharge after AMI to determine the likelihood of near-term adverse events that may eminently jeopardize patient safety.
Based on this analysis, we have implemented interventions to decrease the readmission rate, especially addressed for the first week after discharge. These include having all the medications delivered to bedside before discharge, a checklist with multidisciplinary standard of care parameters, a dedicated hospitalist for AMI and CHF patients, phone call by nurse with standardized questionnaire 3 days after discharge and setting up a high risk follow-up appointment within 1 week, either with our academic clinic or with the attending cardiologist. Follow up analysis will determine the efficacy of these interventions.
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